Plasmapheresis in the Treatment of Refractory Myoclonic Status. A Case Report

Judit Gutierrez-Gutierrez; Reyes Muñoz-Calahorro; Laura Bermejo-Guerrero; Zaira Molina-Collado; Ignacio Saez de la Fuente; Jose Angel Sánchez-Izquierdo

doi:10.2478/jccm-2021-0041

$Plasmapheresis in the Treatment of Refractory Myoclonic Status. A Case Report Cover$

.blurhash-client-img { display: none !important; }

Plasmapheresis in the Treatment of Refractory Myoclonic Status. A Case Report

The Journal of Critical Care Medicine

Volume 7 (2021): Issue 4 (October 2021)

By: Judit Gutierrez-Gutierrez, Reyes Muñoz-Calahorro, Laura Bermejo-Guerrero, Zaira Molina-Collado, Ignacio Saez de la Fuente and Jose Angel Sánchez-Izquierdo

Open Access

|Nov 2021

Abstract

A case of myoclonic status treated with plasmapheresis in a patient of 63 years of age who was admitted to a Spanish intensive care unit is reported. The patient showed clinical and radiological evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; molecular tests did not verify this.

References

Helms J, Kremer S., Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med 2020; 382:22682270.
Search in Google Scholar Back to article
Oxley T., Mocco J., Majidi S., et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med 2020;382:e60
Search in Google Scholar Back to article
Rábano-Suárez P., Bermejo-Guerrero L., Méndez-Guerrero A., et al. Generalized myoclonus in COVID-19. Neurology 2020;95(6): e767-e772
Search in Google Scholar Back to article
Mancuso E, Tanzi G. Paradoxical Reactions to Benzodiazepines: Literature Review and Treatment Options. Pharmacotherapy. 2004;24(9):1177-85.
Search in Google Scholar Back to article
Lee H, Lee J. Lance-Adams Syndrome. Annals of Rehabilitation Medicine. 2011;35:939.
Search in Google Scholar Back to article
Rice J, Nagle S, Randall J, et al. Chimeric Antigen Receptor T Cell-Related Neurotoxicity: Mechanisms, Clinical Presentation, and Approach to Treatment. Curr Treat Options Neurol. 2019;21(8):40.
Search in Google Scholar Back to article
Santomasso BD, Park JH, Salloum D, et al. Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukaemia. Cancer Discov. 2018;8:958–71.
Search in Google Scholar Back to article
Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473‐4
Search in Google Scholar Back to article
Kabaka N, Taskin E, Aydin M. Segmental myoclonus as the presenting symptom of an acute disseminated encephalomyelitis: a case report. Eur J Paediatr Neurol. 2006;10(1):45-8
Search in Google Scholar Back to article
Siddiqui HK, Mehra MR. COVID-19 Illness in Native and Immunosuppressed States: A ClinicalTherapeutic Staging Proposal. J Heart Lung Transplant. 2020 May;39(5):405-7.
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.2478/jccm-2021-0041 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809

Journal RSS Feed

Language: English

Page range: 290 - 293

Submitted on: Oct 8, 2021

Accepted on: Oct 10, 2021

Published on: Nov 6, 2021

Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

Internal medicine, other,

Surgery,

Surgery, other,

Anaesthesiology,

Emergency medicine and intensive-care medicine

© 2021 Judit Gutierrez-Gutierrez, Reyes Muñoz-Calahorro, Laura Bermejo-Guerrero, Zaira Molina-Collado, Ignacio Saez de la Fuente, Jose Angel Sánchez-Izquierdo, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 7 (2021): Issue 4 (October 2021)